Capital Research Global Investors
ZBH icon

Capital Research Global Investors’s Zimmer Biomet ZBH Stock Holding History

Capital Research Global Investors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-603,357
Closed -$79.6M – 446
2024
Q1 		$79.6M Buy
603,357
+2
+0% +$250 0.02% 302
2023
Q4 		$73.4M Sell
603,355
-1,890,095
-76% -$211M 0.02% 298
2023
Q3 		$280M Buy
2,493,450
+134,996
+6% +$17.1M 0.08% 192
2023
Q2 		$343M Buy
2,358,454
+100,139
+4% +$13.6M 0.09% 177
2023
Q1 		$292M Buy
2,258,315
+806
+0% +$101K 0.08% 182
2022
Q4 		$288M Buy
2,257,509
+646,373
+40% +$75M 0.09% 179
2022
Q3 		$168M Sell
1,611,136
-920,258
-36% -$101M 0.06% 218
2022
Q2 		$266M Sell
2,531,394
-809,014
-24% -$96M 0.08% 184
2022
Q1 		$427M Sell
3,340,408
-1,229,955
-27% -$148M 0.11% 170
2021
Q4 		$564M Sell
4,570,363
-1,672,552
-27% -$219M 0.12% 151
2021
Q3 		$887M Sell
6,242,915
-4,320,741
-41% -$636M 0.21% 110
2021
Q2 		$1.65B Sell
10,563,656
-197,701
-2% -$32M 0.38% 65
2021
Q1 		$1.67B Buy
10,761,357
+1,243,387
+13% +$193M 0.41% 54
2020
Q4 		$1.42B Sell
9,517,970
-583,076
-6% -$82.4M 0.37% 68
2020
Q3 		$1.34B Buy
10,101,046
+1,185,286
+13% +$155M 0.4% 57
2020
Q2 		$1.03B Buy
8,915,760
+841,209
+10% +$96.9M 0.33% 72
2020
Q1 		$792M Buy
+8,074,551
New +$1.06B 0.31% 75
2014
Q2 		– Sell
-9,145,267
Closed -$840M – 452
2014
Q1 		$840M Sell
9,145,267
-410,764
-4% -$37.9M 0.3% 95
2013
Q4 		$865M Buy
9,556,031
+206,000
+2% +$17.8M 0.32% 90
2013
Q3 		$746M Buy
9,350,031
+9,373
+0.1% +$738K 0.29% 97
2013
Q2 		$680M Buy
+9,340,658
New +$698M 0.29% 96

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors's ZBH Position: Q2 2024 in Review

Capital Research Global Investors sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 603,357 shares — an estimated $79.6M sold.

Capital Research Global Investors first reported a position in ZBH in Q2 2013 and held it in 21 quarters. The position peaked at $1.67B in Q1 2021. 1,006 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Capital Research Global Investors reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Capital Research Global Investors sold 603,357 Zimmer Biomet shares in Q2 2024, an estimated $79.6M.
  • Capital Research Global Investors first reported a position in Zimmer Biomet in Q2 2013 and held it in 21 quarters.
  • Capital Research Global Investors's Zimmer Biomet position peaked at $1.67B in Q1 2021.
  • 1,006 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Capital Research Global Investors's 13F filing for Q2 2024, filed 13 Aug 2024.